BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 30402332)

  • 1. Oral Administration of Silk Peptide Enhances the Maturation and Cytolytic Activity of Natural Killer Cells.
    Jang SH; Oh MS; Baek HI; Ha KC; Lee JY; Jang YS
    Immune Netw; 2018 Oct; 18(5):e37. PubMed ID: 30402332
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Silk peptide treatment potentiates natural killer cell activity
    Jang SH; Oh MS; Baek HI; Ha KC; Lee JY; Jang YS
    Pharm Biol; 2019 Dec; 57(1):369-379. PubMed ID: 31156004
    [No Abstract]   [Full Text] [Related]  

  • 3. Ethanol suppression of the hypothalamic proopiomelanocortin level and the splenic NK cell cytolytic activity is associated with a reduction in the expression of proinflammatory cytokines but not anti-inflammatory cytokines in neuroendocrine and immune cells.
    Chen CP; Boyadjieva NI; Advis JP; Sarkar DK
    Alcohol Clin Exp Res; 2006 Nov; 30(11):1925-32. PubMed ID: 17067358
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Heat shock protein 70 (Hsp70) stimulates proliferation and cytolytic activity of natural killer cells.
    Multhoff G; Mizzen L; Winchester CC; Milner CM; Wenk S; Eissner G; Kampinga HH; Laumbacher B; Johnson J
    Exp Hematol; 1999 Nov; 27(11):1627-36. PubMed ID: 10560910
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Response of human natural killer (NK) cells to NK cell stimulatory factor (NKSF): cytolytic activity and proliferation of NK cells are differentially regulated by NKSF.
    Robertson MJ; Soiffer RJ; Wolf SF; Manley TJ; Donahue C; Young D; Herrmann SH; Ritz J
    J Exp Med; 1992 Mar; 175(3):779-88. PubMed ID: 1346796
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synergistic effects of IL-2, IL-12 and IL-18 on cytolytic activity, perforin expression and IFN-gamma production of porcine natural killer cells.
    Pintaric M; Gerner W; Saalmüller A
    Vet Immunol Immunopathol; 2008 Jan; 121(1-2):68-82. PubMed ID: 17913242
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Activation of natural killer T cells by NK-4, a criptocyanine dye].
    Kunikata T; Kohno K; Ushio S; Fukuda S
    Yakugaku Zasshi; 2011; 131(11):1667-74. PubMed ID: 22041707
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interferon-gamma: biologic functions and HCV therapy (type I/II) (1 of 2 parts).
    Gattoni A; Parlato A; Vangieri B; Bresciani M; Derna R
    Clin Ter; 2006; 157(4):377-86. PubMed ID: 17051976
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Interferon-beta and recombinant IL 2 can both enhance, but by different pathways, the nonspecific cytolytic potential of T3- natural killer cell-derived clones rather than that of T3+ clones.
    van de Griend RJ; Ronteltap CP; Gravekamp C; Monnikendam D; Bolhuis RL
    J Immunol; 1986 Mar; 136(5):1700-7. PubMed ID: 3005399
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ethanol suppresses polyinosinic:polycytidylic acid-induced activation of natural killer cells primarily by acting on natural killer cells, not through effects on other cell types.
    Hébert P; Pruett SB
    Alcohol; 2002 Oct; 28(2):75-81. PubMed ID: 12457938
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The activation of natural killer cell effector functions by cetuximab-coated, epidermal growth factor receptor positive tumor cells is enhanced by cytokines.
    Roda JM; Joshi T; Butchar JP; McAlees JW; Lehman A; Tridandapani S; Carson WE
    Clin Cancer Res; 2007 Nov; 13(21):6419-28. PubMed ID: 17962339
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of natural killer and natural killer-like T cells derived from ex vivo expanded and activated cord blood mononuclear cells: implications for adoptive cellular immunotherapy.
    Ayello J; van de Ven C; Cairo E; Hochberg J; Baxi L; Satwani P; Cairo MS
    Exp Hematol; 2009 Oct; 37(10):1216-29. PubMed ID: 19638292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin (IL)-23 Stimulates IFN-γ Secretion by CD56
    Ziblat A; Nuñez SY; Raffo Iraolagoitia XL; Spallanzani RG; Torres NI; Sierra JM; Secchiari F; Domaica CI; Fuertes MB; Zwirner NW
    Front Immunol; 2017; 8():1959. PubMed ID: 29403472
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokine-Mediated Activation of NK Cells during Viral Infection.
    Freeman BE; Raué HP; Hill AB; Slifka MK
    J Virol; 2015 Aug; 89(15):7922-31. PubMed ID: 25995253
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Il-21 enhances NK cell activation and cytolytic activity and induces Th17 cell differentiation in inflammatory bowel disease.
    Liu Z; Yang L; Cui Y; Wang X; Guo C; Huang Z; Kan Q; Liu Z; Liu Y
    Inflamm Bowel Dis; 2009 Aug; 15(8):1133-44. PubMed ID: 19322899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Interleukin-12 promotes the proliferation and cytolytic maturation of immune effectors: implications for the immunotherapy of cancer.
    Zeh HJ; Hurd S; Storkus WJ; Lotze MT
    J Immunother Emphasis Tumor Immunol; 1993 Aug; 14(2):155-61. PubMed ID: 7904180
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vivo activation of natural killer cells and priming of IL-2 responsive cytolytic cells by loxoribine (7-allyl-8-oxoguanosine).
    Pope BL; Chourmouzis E; Sigindere J; MacIntyre JP; Capetola RJ; Lau CY
    Cell Immunol; 1993 Apr; 147(2):302-12. PubMed ID: 8453674
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cytokine production and killer activity of NK/T-NK cells derived with IL-2, IL-15, or the combination of IL-12 and IL-18.
    Lauwerys BR; Garot N; Renauld JC; Houssiau FA
    J Immunol; 2000 Aug; 165(4):1847-53. PubMed ID: 10925263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Requirement for natural killer cell-produced interferon gamma in defense against murine cytomegalovirus infection and enhancement of this defense pathway by interleukin 12 administration.
    Orange JS; Wang B; Terhorst C; Biron CA
    J Exp Med; 1995 Oct; 182(4):1045-56. PubMed ID: 7561678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mechanisms of bacillus Calmette-Guerin mediated natural killer cell activation.
    Suttmann H; Jacobsen M; Reiss K; Jocham D; Böhle A; Brandau S
    J Urol; 2004 Oct; 172(4 Pt 1):1490-5. PubMed ID: 15371877
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.